Lars Wallentin
Lars Wallentin is an expert in Cardiology at Uppsala University (Sweden). As of October 2026, ScienceLeadR ranks Lars Wallentin in the top 1% of experts worldwide for Myocardial Ischemia, Atrial Fibrillation and Coronary Disease. Lars Wallentin has authored 1,185 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 4,880 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Hematology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 1185
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Response by Oldgren and Wallentin to Letter Regarding Article, "Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study". PMID 42766685 — registries, stroke, cardiovascular system, atrial fibrillation, biomarkers, therapeutics, blood circulation | Circulation Top journal | 2026 | 0 |
| Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. PMID 42549517 — anticoagulants, hemorrhage, stroke, incidence, cardiovascular system, atrial fibrillation, warfarin, blood circulation, direct-acting oral anticoagulants | Circulation Top journal | 2026 | 0 |
| Outcomes With Warfarin in Atrial Fibrillation: Individual Patient Data Analysis From Four Randomized Trials. PMID 42489390 — stroke, atrial fibrillation, data analysis, warfarin, direct-acting oral anticoagulants | JACC Adv | 2026 | 1 |
| Heterogeneity of Treatment Effect of DOACs vs Warfarin in Atrial Fibrillation. PMID 42489381 — creatinine, anticoagulants, stroke, atrial fibrillation, machine learning, therapeutics, warfarin, direct-acting oral anticoagulants | JACC Adv | 2026 | 0 |
| DOAC Score Among Patients Receiving Vitamin K Antagonists. PMID 42336120 — registries, hemorrhage, vitamins, atrial fibrillation, cardiology, vitamin k, warfarin, blood circulation, direct-acting oral anticoagulants | Am Heart J | 2026 | 0 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Stroke Prevention and Rhythm Control Therapy STEEER AF NCT04396418 — guideline adherence, stroke, atrial fibrillation, cardiology, therapeutics, education, random allocation | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map